Madrigal CCO Disposes $449K in Stock as Company Posts Strong Drug Launch and Pipeline Moves
Carole Huntsman, Chief Commercial Officer of Madrigal Pharmaceuticals (MDGL), sold 910 shares of common stock on January 26, 2026, across two transactions totaling $449,338. One sale was automatic to satisfy tax withholdings tied to restricted stock unit vesting; the other occurred under a pre-arranged Rule 10b5-1 plan. The company, with an $11.3 b…